reason report weekli
last week medic devic index outperform broad
market index increas week
versu gain result medic
devic hospit suppli index continu outperform
versu year-to-d loss
announc preliminari revenu million
modest annual report term constant
currenc adjust recent divestitur dynam control
compani sale result reflect growth respiratori
mobil product addit indic quarterli oper
loss adjusted-ebitda free cash flow favor compar
prior-year period possess estim million
cash inclus million proce previous
announc sale dynam control appli motion control
rate simpli put view oper result
favor remain encourag compani right-track
either meet exceed oper object
also tuesday e/v rate elgx announc compani
appoint tim benner succeed john zehren compani
elgx decad experi medic devic industri
recent serv gener manag divis vice presid
 region abbott rate structur heart
busi prior mr benner held variou posit edward
global market commerci oper market develop
addit serv ew senior leadership
encourag today announc view mr benner
strong addit elgx team due proven divers
background medic devic industri
wednesday april o/v rate announc compani
receiv permiss fda ship
patient importantli aim manufactur sensor
hospit patient use compani remot
share featur provid abl receiv patient data remot
contrast offer one must manual scan sensor
import disclosur analyst certif page report report constitut compendium report cover six
subject compani stephen inc choos provid specif disclosur compani mention refer
access current disclosur compani report client refer
contact stephen inc repres addit inform
thursday april e/v rate announc expans compani financi assist program
custom lost job insur due cover medicaid insur
meet certain financi criteria recipi may receiv suppli pod free charg furthermor
program schedul run decemb first pass assum domest instal
base util program estim enhanc assist program creat million million
headwind sale equival modest reduct report domest sale growth
also thursday rate announc compani btg specialti btg divis execut
agreement soligenix inc rate sngx exclus global licens btg covaccin ht novel
vaccin importantli covaccin ht shown enhanc cell-medi antibody-medi
immun addit demonstr success heat stabl filoviru vaccin program candid
ebola marburg viru diseas result covaccin ht potenti import part sngx vaccin
platform use coronavirus includ
friday april reduc estim maintain o/v invest rate price
target share result recent discuss gener intervent cardiologist march
april suggest domest pci procedur volum declin excess relat procedur
volum improv exit calendar period simpli put asymptomat ischem patient temporarili
gone hide cardiolog clinic patient unfortun coronari diseas progress
requir treatment near futur result assum pronounc downturn relat procedur
volum improv sequenti throughout year exist backlog address new patient return
clinic subsequ pull pipelin also note social distanc creat greater challeng
near-term educ develop protected-pci referr commun
also publish note highlight takeway expert call host thursday april investor
mr darin dj hill co-found ceo compass surgic group privat better assess current state
surgic procedur volum trend nuanc associ expect subsequ recoveri mr hill
perspect base year industri experi also note compass surgic group
lead owner oper physician hospit joint ventur across corpor center
enjoy industry-lead track record clinic financi perform opinion three salient
takeaway rel medic devic hospit suppli coverag univers includ limit
expect procedur growth ramp slow signific backlog exist spine ortho case
estim elig case defer
announc success complet follow-on offer issu million share per share
repres discount close price rais gross proce million anticip
underwrit allot share execut bring total gross proce million result
dilut sharehold exit million cash cash equival debt
offer like lend increment million net liquid earmark gener corpor purpos
result offer lower non-gaap earn estim reflect dilut
follow-on offer
tuesday april johnson johnson rate report oper result provid
oper guidanc importantli assum advers affect acut near-term
impact recoveri procedur begin stabil recov subsequ improv
specif elect procedur asiapacif region forecast declin
strengthen calendar year likewis assum defer procedur combin
itali franc germani spain russian market declin declin
stabil occur
north carolina repres ted budd introduc bill would ban use feder fund purchas chinese-
manufactur drug addit requir hh creat two list one origin import drug second
medic sold ingredi china furthermor bill design ensur
drug activ pharmaceut ingredi purchas feder health program countri
china
furthermor insidehealthpolici report senat minor leader chuck schumer senat patti murray
senat ron wyden alleg hh correctli follow congress intent distribut billion care
act fund provid furthermor group senat demand balanc fund distribut
target locat hardest hit lastli group alleg hh use billion fund
polit tool reimburs hospit treatment uninsur patient
wednesday april vivev medic inc rate vive announc compani resubmit
fda compani cmrf treatment order begin stress urinari incontin multicent random double-
blind sham-control trial titl pursuit importantli compani discuss fda
believ resubmiss address specif protocol request includ posit result addit vivo anim
safeti test request agenc studi enrol patient site across
hour pad weight test month post-treat primari efficaci endpoint
note dollar million except per share data ep alc
elgx fulli tax pro forma
rate stephen inc overweight equal-weight underweight volatil susp suspend
percentag chang price
insulet corporati
insulet corporati
edward lifesci corporati
compani document stephen inc estim rate
stephen inc otherwis estim base upon consensu
list figur page
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
